Author

Kevin Treine

Observed names: K., Treine, Kevin E. Treine

Institutions: Johns Hopkins University, Johns Hopkins Medicine

Observed institutions: Johns Hopkins University, Johns Hopkins Medicine

OpenAlex ID: A5038726569

Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial

2025 · Issam A Awad, Roberto J Alcazar-Felix, et al. · The Lancet Neurology · 16

Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical Outcome

2023 · Kelly D. Flemming, Helen Kim, et al. · Stroke · 13

Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling

2023 · Stephanie Hage, Serena Kinkade, et al. · Stroke · 13

Hydroxyurea to prevent brain injury in children with sickle cell disease ( HU Prevent)—A randomized, placebo‐controlled phase II feasibility/pilot study

2024 · James F. Casella, Dana K. Furstenau, et al. · American Journal of Hematology · 12

Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial Modeling

2023 · Stephanie Hage, Serena Kinkade, et al. · medRxiv · 2

Abstract P46: Baseline Characteristics of Patients With Cerebral Cavernous Angiomas With Symptomatic Hemorrhage in a Multisite Trial Readiness Study

2021 · Helen Kim, Kelly Flemming, et al. · Stroke · 1

A multicenter randomized pragmatic trial comparing intra-articular injection, genicular nerve block, and radiofrequency ablation for knee osteoarthritis pain: SKOAP Phase 2 protocol

2026 · Steven P Cohen, Daniel O Scharfstein, et al. · Pain Medicine

Functional and Patient-Reported Outcomes in the Atorvastatin versus Placebo Trial of Hemorrhagic Cerebral Cavernous Malformations: An Exploratory Study

2026 · Georgeio Sader, Roberto J. Alcazar-Felix, et al. · Cerebrovascular Diseases

Supplementary Material for: Functional and Patient-reported Outcomes in the Atorvastatin versus Placebo Trial of Hemorrhagic Cerebral Cavernous Malformations: An Exploratory Study

2026 · karger, figshare admin, G., Sader, et al. · Figshare

Abstract TP375: Assessment of Functional Outcome in the AT CASH EPOC Trial of Hemorrhagic Cerebral Cavernous Malformations

2026 · Roberto Alcazar, Georgeio Sader, et al. · Stroke

Abstract 121: Prospective Symptomatic Hemorrhage Rates And Functional Outcomes In Trial Eligible Cavernous Angiomas With Symptomatic Hemorrhage

2023 · Kelly Flemming, Jay Mandrekar, et al. · Stroke

Works count: 11

Citation count: 57

H-index: 4

I10-index: 4